OCEANIC-AF and the inferior efficacy of asundexian compared to apixaban in patients at high risk with atrial fibrillation: Have we come to the end of the road for factor XIa inhibitors?

Autor: Keith C. Ferdinand, Asaad Nakhle

Publikováno v: American Heart Journal Plus, Vol 46, Iss , Pp 100464- (2024)

Externí odkaz: https://doaj.org/article/d4dffdffaffe4b5fbf20deb1fc98faf2

Communicating to Non-Speaking Critically Ill Patients: Augmentative and Alternative Communication Technique as an Essential Strategy

Autor: Asaad Nasser Salim Al-Yahyai, RN, BSN, Judie Arulappan, RN, RM, BSC (N), MSC (N), PhD (N), DNSc, Gerald Amandu Matua RN, BSN, MSN, PhD, Sultan Marhoon Al-Ghafri, RN, BSN, Sami Hamood Al-Sarakhi, RN, BSN, Khalid Khalfan Said Al-Rahbi, RN, BSN, Sathish Kumar Jayapal MSC (N), PhD

Publikováno v: SAGE Open Nursing, Vol 7 (2021)

Introduction Communication with hospitalized patients is crucial to improve the quality and safety of health care. Methods The study assessed the communication methods used by nurses while communicating to non-speaking critically ill patients. The pa

Externí odkaz: https://doaj.org/article/6426ba718a8245d9b1e11b8d759731b2

Determinants of behavioral intentions to screen for prostate cancer in Omani men

Autor: Joshua Kanaabi Muliira, Hazaa Sami Al-Saidi, Asaad Nasser Al-Yahyai

Publikováno v: Asia-Pacific Journal of Oncology Nursing, Vol 4, Iss 4, Pp 348-355 (2017)

Objective: This study aimed at exploring the perceived barriers and intention to screen for prostate cancer (PCa). Methods: A survey questionnaire and a descriptive design were used to collect data from 129 Omani men above the age of 40 years. The qu

Externí odkaz: https://doaj.org/article/dbafec547f3a4ccaaf387157fe7da39e

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar.

Autor: Butt AA; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar. aabutt@hamad.qa.; Department of Medicine, Weill Cornell Medicine, New York, NY, USA. aabutt@hamad.qa.; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY, USA. aabutt@hamad.qa.; Department of Medicine, Weill Cornell Medicine, Doha, Qatar. aabutt@hamad.qa.; Department of Population Health Sciences, Weill Cornell Medicine, Doha, Qatar. aabutt@hamad.qa., Guerrero MD; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar., Canlas EB; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar., Al-Dwairi H; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar., Alimam ABMA; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Mohamad AR; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Ali MT; Heart Hospital, Hamad Medical Corporation, Doha, Qatar., Asaad NA; Heart Hospital, Hamad Medical Corporation, Doha, Qatar., Alkeldi AASS; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar., Mohammad MFS; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar., Thomas AG; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar., Al-Khal A; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Al-Maslamani M; Communicable Diseases Center, Hamad Medical Corporation, Doha, Qatar., Abou-Samra AB; Corporate Quality and Patient Safety Department, Hamad Medical Corporation, Doha, Qatar.; Department of Medicine, Weill Cornell Medicine, Doha, Qatar.

Publikováno v: Nature communications [Nat Commun] 2023 Jan 03; Vol. 14 (1), pp. 24. Date of Electronic Publication: 2023 Jan 03.

Hospital admission rates, length of stay, and in-hospital mortality for common acute care conditions in COVID-19 vs. pre-COVID-19 era.

Autor: Butt AA; Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medical College, Doha, Qatar; Weill Cornell Medical College, New York, NY, USA. Electronic address: aabutt@hamad.qa., Kartha AB; Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medical College, Doha, Qatar; Weill Cornell Medical College, New York, NY, USA. Electronic address: akartha@hamad.qa., Masoodi NA; Hamad Medical Corporation, Doha, Qatar. Electronic address: nmasoodi@hamad.qa., Azad AM; Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medical College, Doha, Qatar; Weill Cornell Medical College, New York, NY, USA. Electronic address: aazad@hamad.qa., Asaad NA; Hamad Medical Corporation, Doha, Qatar; Weill Cornell Medical College, Doha, Qatar; Weill Cornell Medical College, New York, NY, USA. Electronic address: nasaad@hamad.qa., Alhomsi MU; Hamad Medical Corporation, Doha, Qatar. Electronic address: malhomsi@hamad.qa., Saleh HAH; Hamad Medical Corporation, Doha, Qatar. Electronic address: hsaleh1@hamad.qa., Bertollini R; Ministry of Public Health, Doha, Qatar. Electronic address: rbertollini@moph.gov.qa., Abou-Samra AB; Hamad Medical Corporation, Doha, Qatar. Electronic address: asamra@hamad.qa.

Publikováno v: Public health [Public Health] 2020 Dec; Vol. 189, pp. 6-11. Date of Electronic Publication: 2020 Sep 21.